文献速递认知障碍与痴呆

老年人皮层蛋白与认知韧性的个体差异

Cortical Proteins and Individual Differences in Cognitive Resilience in Older Adults.
PubMed 文献 · Neurology · 2022-03-03

研究纳入1192名已故老年人,利用背侧前额叶皮层226种蛋白肽段构建认知韧性指数,发现52种肽段与认知韧性相关,较高指数与较慢认知和运动衰退、较低AD病理负荷相关,并可修饰AD病理对认知的影响。

要点

  • 从226种皮层肽段中筛选出52种与认知韧性相关并构建个体化指数。
  • 较高韧性指数与较慢认知衰退和运动衰退相关。
  • 较高指数与较低AD病理负荷相关,并修饰AD病理对认知的影响。

核心结论

  • 皮层蛋白可能提供一定程度的认知韧性,这些多功能蛋白似乎也提供对其他AD临床表型的韧性,并与ADRD病理有独立关联。
  • 韧性蛋白可能成为药物发现的高价值治疗靶点,用于通过多通路维持老年人脑健康的干预措施。

研究设计与样本

  • 研究使用1192名已故老年人的数据,包括年度临床测试、10种阿尔茨海默病(AD)及相关痴呆(ADRD)病理指标以及背侧前额叶皮层中226种蛋白型肽段的测量。
  • 采用线性混合效应模型识别与认知韧性相关的肽段(错误发现率<0.05),并将这些韧性肽段的表达水平聚合为个体特异性认知韧性指数。

主要发现

  • 从226种肽段中构建了由52种与认知韧性相关的肽段组成的韧性指数。
  • 较高指数与较慢认知衰退相关(估计值0.05,标准误0.003,p<0.001)和较慢运动衰退相关(估计值0.005,标准误0.001,p<0.001)。
  • 大多数韧性肽段(70%)对认知衰退特异,但30%也对运动衰退提供韧性。
  • 较高指数与较低AD病理负荷相关(比值比[OR]0.41,标准误0.01,p<0.001),并修饰AD病理与认知的关联,较高指数修饰了AD病理对临终前AD痴呆的负性效应(OR 0.70,标准误0.14,p=0.010)。
  • 高达90%的认知韧性肽段与AD病理表型相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Cognitive resilience is a well-recognized concept, but knowledge gaps about its underlying mechanisms have made it difficult to develop instruments that identify older adults with high or low resilience. We tested whether aggregating cortical peptides associated with cognitive resilience into an index can identify adults with higher or lower cognitive resilience. METHODS: We used data from 1,192 older decedents, including annual clinical testing, indices of 10 Alzheimer disease (AD) and related dementia (ADRD) pathologies, and 226 proteotypic peptides measured in the dorsal lateral prefrontal cortex. We used linear mixed-effects models to identify peptides that were related to cognitive resilience (i.e., cognitive decline not explained by ADRD pathologies [false discovery rate <0.05]). We aggregated the expression levels of these resilience peptides into a person-specific cognitive resilience index and examined its association with AD clinical and pathologic phenotypes. RESULTS: We constructed a resilience index from 52 of 226 peptides related to cognitive resilience. A higher index was associated with slower cognitive decline (estimate 0.05, SE 0.003, p < 0.001) and slower motor decline (estimate 0.005, SE 0.001, p < 0.001). Most resilience peptides (70%) were specific to cognitive decline, but 30% also provided resilience for motor decline. A higher index was also related to a lower burden of AD pathologies (odds ratio [OR] 0.41, SE 0.01, p < 0.001) and modified the association of AD pathology with cognition in that a higher index modified the negative effects of AD pathology on AD dementia proximate to death (OR 0.70, SE 0.14, p = 0.010). Up to 90% of cognitive resilience peptides were related to AD pathologic phenotypes. DISCUSSION: Cortical proteins may provide some degree of cognitive resilience. These multifunctional proteins also seem to provide resilience to other AD clinical phenotypes and have independent associations with ADRD pathologies. Resilience proteins may be high-value therapeutic targets for drug discovery of interventions that maintain brain health in aging adults via multiple pathways.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Zammit AR, Yu L, Petyuk V, et al. Cortical Proteins and Individual Differences in Cognitive Resilience in Older Adults. Neurology. 2022. PMID: 35241503. doi:10.1212/WNL.0000000000200017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。